Filtered By:
Condition: Headache
Management: Centers for Disease Control and Prevention (CDC)
Countries: USA Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

How to Keep Your Home Cool in Extreme Heat
Global temperatures have reached alarmingly high levels across the U.S., Europe, and Asia as heat waves set record highs this week. Parts of European countries including most of Italy, eastern Croatia, southern Spain, southern Bosnia and Herzegovina, and Montenegro are under red alert, the European Union’s Emergency Response Coordination Centre said on Wednesday. Meanwhile, as of July 18, Phoenix had experienced 19 consecutive days of 110°F temperatures or higher. And Beijing is also experiencing a record stretch of 95°F heat. The extreme heat comes as weather phenomenon El Niño, which occurs every tw...
Source: TIME: Health - July 19, 2023 Category: Consumer Health News Authors: Solcyre Burga Tags: Uncategorized climate change extreme weather healthscienceclimate Source Type: news

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news